Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today it has received its first purchase orders for its Equashield Pro closed ...

Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, today announced the results of a study conducted by the University of North Carolina's ...

PORT WASHINGTON, N.Y., May 13, 2024 /PRNewswire/ -- EQUASHIELD ®, a global leader in the development and distribution of Closed System Transfer Devices (CSTDs) and pharmacy automation solutions, marks ...

Satellite Symposium at ISOPP 2018Focusing on Robotics in Cytotoxics to Feature Leading Experts an Augmented Reality Tour of Equashield Pro Hazardous Drug Compounding Robot Equashield (equashield.com), ...

TEL AVIV, April 17 (Reuters) - Israeli medical device maker Equashield expects its sales to grow by more than 60 percent a year as more hospitals invest in its sealed syringes to protect healthcare ...

PORT WASHINGTON, N.Y., Sept. 8, 2023 /PRNewswire/ -- EQUASHIELD, a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its ...

The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...

EQUASHIELD , a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its remarkable achievement of being named by the Pharmacy ...

University of North Carolina's Eshelman School of Pharmacy studypublished in the Journal of Oncology Pharmacy Practice Equashield (equashield.com), a leading provider of Closed System Transfer Devices ...